[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$immx

Immix Biopharma's CAR-T therapy shows promising Phase X results, with analysts raising PT to $XX and reiterating a Buy rating. The company's stock is experiencing strong bullish momentum following positive data presentations.

About $immx

Immix Biopharma is a biotechnology company focused on developing CAR-T therapies.

Insights

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXXX +34%
X Month: XXXXXXX +81%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX +67%
1-Year High: XXXXXXX on 2024-12-13
1-Year Low: XXX on 2025-01-27

Engagements by network (24h): Reddit: XX X: XXXXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXX +2.40%
X Months: XXXXX -X%
X Year: XXXXXX +227%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-09-23

Mentions by network (24h): Reddit: XX X: XXX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $immx in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XX +49%
X Month: XXX +87%
X Months: XXX +128%
X Year: XXXXX +445%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-01-28

The most influential creators that mention $immx in the last XX hours

Creator Rank Followers Posts Engagements
@ProTraderK X XX XX XXX
@BiotechPort X XXXXX X XXX
@Fredbenz0 X XXXXX X XX
@monaco_biotech X XXXXX X XX
@SeanValenc89161 X XX X XX
@TheOptionsBull2 X XXX X XX
@digamymagadisg88 X XXXXX X XX
@Chat3Free X XXX X XX
@Stockma01861822 X XXX X X

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2024-12-26
1-Year Low: XX% on 2025-12-11

Most Supportive Themes:

Most Critical Themes:

Top $immx Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Discord- better more executive trading chat room $GOOG $RDDT $ICU $IVP $VVPR $CNSP $IMMX $POET $GDXU $RELI $ABSI $SPY $GME $OPTT $NVDA $HOLO $DJT $QQQ $ZCAR $MULN $AAPL"
X Link @ProTraderK 2025-12-11T04:22Z XX followers, XXX engagements

"performing well in our community🔥 🚀 $PARA $ANVS $DOYU $KOSS $STZ $TSLA $RDDT $ICU $IVP $VVPR $CNSP $IMMX $POET $GDXU $DJT $QQQ $MULN $AAPL $AMZN $AMC"
X Link @Top_Markting 2025-12-11T04:20Z XX followers, XX engagements

"H.C. Wainwright y'day $IMMX's PT to $XX from $X plusPoS to XX% and reiterated at a Buy rating. $PRTA $AZN JNJ ABBV TAK BMY SNY H.C. Wainwright said in its note: Over the weekend at the annual ASH meeting Immix presented Phase X results from the NEXICART-2 trial which is evaluating NXC-201 (a BCMA-targeted autologous CAR-T) in r/r AL amyloidosis. As shown in the oral presentation NXC-201 (n=20; X median prior Rx) demonstrated a XX% hematologic CR rate (15/20) with XX of XX evaluable patients being MRD-negative (see Figure X below). Notably four of five patients pending evaluation are"
X Link @Quantumup1 2025-12-10T13:58Z 3927 followers, 3133 engagements

"We give entries & exits free Chatroom link below🙏🙏 $COST $QQQ $ZCAR $MULN $AAPL $AMZN $AMC $PARA $ANVS $DOYU $KOSS $STZ $TSLA $IMMX $POET $GDXU $RELI $ABSI $SPY"
X Link @ProTraderK 2025-12-10T05:36Z XX followers, XX engagements